156 related articles for article (PubMed ID: 35315178)
21. Identification of lncRNA-associated competing endogenous RNA networks for occurrence and prognosis of gastric carcinoma.
Ye L; Jin W
J Clin Lab Anal; 2021 Dec; 35(12):e24028. PubMed ID: 34704289
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Novel Ferroptosis-Related LncRNA Signature for Predicting Prognosis and the Immune Landscape Features in Uveal Melanoma.
Ma X; Yu S; Zhao B; Bai W; Cui Y; Ni J; Lyu Q; Zhao J
Front Immunol; 2022; 13():922315. PubMed ID: 35774794
[TBL] [Abstract][Full Text] [Related]
23. Integrated analysis of long non-coding RNA competing interactions reveals the potential role in progression of human gastric cancer.
Li CY; Liang GY; Yao WZ; Sui J; Shen X; Zhang YQ; Peng H; Hong WW; Ye YC; Zhang ZY; Zhang WH; Yin LH; Pu YP
Int J Oncol; 2016 May; 48(5):1965-76. PubMed ID: 26935047
[TBL] [Abstract][Full Text] [Related]
24. Testing lncRNAs signature as clinical stage-related prognostic markers in gastric cancer progression using TCGA database.
Beeraka NM; Gu H; Xue N; Liu Y; Yu H; Liu J; Chen K; Nikolenko VN; Fan R
Exp Biol Med (Maywood); 2022 Apr; 247(8):658-671. PubMed ID: 35068210
[TBL] [Abstract][Full Text] [Related]
25. A risk score model with five long non-coding RNAs for predicting prognosis in gastric cancer: an integrated analysis combining TCGA and GEO datasets.
Wu Y; Deng J; Lai S; You Y; Wu J
PeerJ; 2021; 9():e10556. PubMed ID: 33614260
[TBL] [Abstract][Full Text] [Related]
26. A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer.
Liu SJ; Yang YB; Zhou JX; Lin YJ; Pan YL; Pan JH
Dis Markers; 2021; 2021():2385406. PubMed ID: 34868391
[TBL] [Abstract][Full Text] [Related]
27. The lncRNA BDNF-AS/WDR5/FBXW7 axis mediates ferroptosis in gastric cancer peritoneal metastasis by regulating VDAC3 ubiquitination.
Huang G; Xiang Z; Wu H; He Q; Dou R; Lin Z; Yang C; Huang S; Song J; Di Z; Wang S; Xiong B
Int J Biol Sci; 2022; 18(4):1415-1433. PubMed ID: 35280682
[TBL] [Abstract][Full Text] [Related]
28. Identification of functional lncRNAs in gastric cancer by integrative analysis of GEO and TCGA data.
Zhang X; Zhang W; Jiang Y; Liu K; Ran L; Song F
J Cell Biochem; 2019 Oct; 120(10):17898-17911. PubMed ID: 31135068
[TBL] [Abstract][Full Text] [Related]
29. Identification of a Ferroptosis-Related LncRNA Signature as a Novel Prognosis Model for Lung Adenocarcinoma.
Lu L; Liu LP; Zhao QQ; Gui R; Zhao QY
Front Oncol; 2021; 11():675545. PubMed ID: 34249715
[TBL] [Abstract][Full Text] [Related]
30. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
31. Ferroptosis-related long non-coding RNA signature predicts the prognosis of bladder cancer.
Hou J; Lu Z; Cheng X; Dong R; Jiang Y; Wu G; Qu G; Xu Y
BMC Cancer; 2022 Jun; 22(1):719. PubMed ID: 35768833
[TBL] [Abstract][Full Text] [Related]
32. A ferroptosis-related lncRNA signature predicts prognosis in ovarian cancer patients.
Peng J; Hao Y; Rao B; Zhang Z
Transl Cancer Res; 2021 Nov; 10(11):4802-4816. PubMed ID: 35116333
[TBL] [Abstract][Full Text] [Related]
33. Identification of the ferroptosis-related long non-coding RNAs signature to improve the prognosis prediction and immunotherapy response in patients with NSCLC.
Li M; Zhang Y; Fan M; Ren H; Chen M; Shi P
BMC Med Genomics; 2021 Dec; 14(1):286. PubMed ID: 34861872
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
[TBL] [Abstract][Full Text] [Related]
35. Identification of the three subtypes and the prognostic characteristics of stomach adenocarcinoma: analysis of the hypoxia-related long non-coding RNAs.
Fan Z; Wang Y; Niu R
Funct Integr Genomics; 2022 Oct; 22(5):919-936. PubMed ID: 35665866
[TBL] [Abstract][Full Text] [Related]
36. LncRNAs Target Ferroptosis-Related Genes and Impair Activation of CD4
Yao F; Zhan Y; Pu Z; Lu Y; Chen J; Deng J; Wu Z; Chen B; Chen J; Tian K; Ni Y; Mou L
Front Cell Dev Biol; 2021; 9():797339. PubMed ID: 34966745
[TBL] [Abstract][Full Text] [Related]
37. Development and validation of a ferroptosis-related prognostic model for the prediction of progression-free survival and immune microenvironment in patients with papillary thyroid carcinoma.
Huang Y; Xie Z; Li X; Chen W; He Y; Wu S; Li X; Hou B; Sun J; Wang S; He Y; Jiang H; Lun Y; Zhang J
Int Immunopharmacol; 2021 Dec; 101(Pt A):108156. PubMed ID: 34624650
[TBL] [Abstract][Full Text] [Related]
38. Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma.
Yang X; Mei M; Yang J; Guo J; Du F; Liu S
Aging (Albany NY); 2022 May; 14(9):4069-4084. PubMed ID: 35550563
[TBL] [Abstract][Full Text] [Related]
39. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer.
Wu Z; Lu Z; Li L; Ma M; Long F; Wu R; Huang L; Chou J; Yang K; Zhang Y; Li X; Hu G; Zhang Y; Lin C
Front Immunol; 2021; 12():783362. PubMed ID: 35154072
[TBL] [Abstract][Full Text] [Related]
40. Prediction of overall survival based upon a new ferroptosis-related gene signature in patients with clear cell renal cell carcinoma.
Sun Z; Li T; Xiao C; Zou S; Zhang M; Zhang Q; Wang Z; Zhan H; Wang H
World J Surg Oncol; 2022 Apr; 20(1):120. PubMed ID: 35422048
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
